HOXB13 mutations in a population-based, case-control study of prostate cancer

Prostate

Volumn 73, Issue 6, 2013, Pages 634-641

  Stott Miller, Marni ^a   Karyadi, Danielle M ^b   Smith, Tiffany ^b   Kwon, Erika M ^b   Kolb, Suzanne ^a   Stanford, Janet L ^a,c   Ostrander, Elaine A ^b  

^a USA   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

genetic susceptibility; genetics; polymorphism; population genetics; prostate cancer; prostate neoplasm

Indexed keywords

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FAMILY HISTORY; GENE FREQUENCY; GENE MUTATION; GLEASON SCORE; HETEROZYGOTE; HOX GENE; HOXB13 GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RISK FACTOR;

ADULT; AGED; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GENOTYPE; HISTORY, 16TH CENTURY; HOMEODOMAIN PROTEINS; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; POINT MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; RISK FACTORS; WASHINGTON;

EID: 84875790154     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22604     Document Type: Article

References (28)

1. Siegel R, Naishadham D, Jemal A,. Cancer statistics 2012. CA: A Cancer J Clinicians 2012; 62 (1): 10-29.
2. Whittemore AS, Wu AH, Kolonel LN, John EM, Gallagher RP, Howe GR, West DW, Teh CZ, Stamey T,. Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Am J Epidemiol 1995; 141 (8): 732-740.
3. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K,. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343 (2): 78-85.
4. Schaid DJ,. The complex genetic epidemiology of prostate cancer. Hum Mol Genet 2004; 1 (13): R103-R121.
5. Easton DF, Schaid DJ, Whittemore AS, Isaacs WJ,. Where are the prostate cancer genes?-A summary of eight genome wide searches. Prostate 2003; 57 (4): 261-269.
6. Ostrander EA, Markianos K, Stanford JL,. Finding prostate cancer susceptibility genes. Annu Rev Genomics Hum Genet 2004; 5: 151-175.
7. Levin AM, Machiela MJ, Zuhlke KA, Ray AM, Cooney KA, Douglas JA,. Chromosome 17q12 variants contribute to risk of early-onset prostate cancer. Cancer Res 2008; 68 (16): 6492-6495.
8. Lange EM, Gillanders EM, Davis CC, Brown WM, Campbell JK, Jones M, Gildea D, Riedesel E, Albertus J, Freas-Lutz D, Markey C, Giri V, Dimmer JB, Montie JE, Trent JM, Cooney KA,. Genome-wide scan for prostate cancer susceptibility genes using families from the University of Michigan prostate cancer genetics project finds evidence for linkage on chromosome 17 near BRCA1. Prostate 2003; 57 (4): 326-334.
9. Gillanders EM, Xu J, Chang BL, Lange EM, Wiklund F, Bailey-Wilson JE, Baffoe-Bonnie A, Jones M, Gildea D, Riedesel E, Albertus J, Isaacs SD, Wiley KE, Mohai CE, Matikainen MP, Tammela TL, Zheng SL, Brown WM, Rokman A, Carpten JD, Meyers DA, Walsh PC, Schleutker J, Gronberg H, Cooney KA, Isaacs WB, Trent JM,. Combined genome-wide scan for prostate cancer susceptibility genes. J Natl Cancer Inst 2004; 96 (16): 1240-1247.
10. Xu J, Dimitrov L, Chang BL, Adams TS, Turner AR, Meyers DA, Eeles RA, Easton DF, Foulkes WD, Simard J, Giles GG, Hopper JL, Mahle L, Moller P, Bishop T, Evans C, Edwards S, Meitz J, Bullock S, Hope Q, Hsieh CL, Halpern J, Balise RN, Oakley-Girvan I, Whittemore AS, Ewing CM, Gielzak M, Isaacs SD, Walsh PC, Wiley KE, Isaacs WB, Thibodeau SN, McDonnell SK, Cunningham JM, Zarfas KE, Hebbring S, Schaid DJ, Friedrichsen DM, Deutsch K, Kolb S, Badzioch M, Jarvik GP, Janer M, Hood L, Ostrander EA, Stanford JL, Lange EM, Beebe-Dimmer JL, Mohai CE, Cooney KA, Ikonen T, Baffoe-Bonnie A, Fredriksson H, Matikainen MP, Tammela T, Bailey-Wilson J, Schleutker J, Maier C, Herkommer K, Hoegel JJ, Vogel W, Paiss T, Wiklund F, Emanuelsson M, Stenman E, Jonsson BA, Gronberg H, Camp NJ, Farnham J, Cannon-Albright LA, Seminara D,. A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. Am J Hum Genet 2005; 77 (2): 219-229.
11. Lange EM, Robbins CM, Gillanders EM, Zheng SL, Xu J, Wang Y, White KA, Chang BL, Ho LA, Trent JM, Carpten JD, Isaacs WB, Cooney KA,. Fine-mapping the putative chromosome 17q21-22 prostate cancer susceptibility gene to a 10 cM region based on linkage analysis. Hum Genet 2007; 121 (1): 49-55.
12. Ewing CM, Ray AM, Lange EM, Zuhlke KA, Robbins CM, Tembe WD, Wiley KE, Isaacs SD, Johng D, Wang Y, Bizon C, Yan G, Gielzak M, Partin AW, Shanmugam V, Izatt T, Sinari S, Craig DW, Zheng SL, Walsh PC, Montie JE, Xu J, Carpten JD, Isaacs WB,. Cooney KA Germline mutations in HOXB13 and prostate-cancer risk. N Engl J Med 2012; 12 (366): 141-149.
13. Jeong TO, Oh KJ, Xuan Nguyen NT, Kim YR, Kim MS, Lee SD, Ryu SB, Jung C,. Evaluation of HOXB13 as a molecular marker of recurrent prostate cancer. Mol Med Report 2012; 5 (4): 901-904.
14. Breyer JP, Avritt TG, McReynolds KM, Dupont WD, Smith JR,. Confirmation of the HOXB13 G84E Germline Mutation in Familial Prostate Cancer. Cancer Epidemiol Biomarkers Prev 2012; 21 (8): 1348-1353.
15. Lin X, Qu L, Chen Z, Xu C, Ye D, Shao Q, Wang X, Qi J, Chen Z, Zhou F, Wang M, Wang Z, He D, Wu D, Gao X, Yuan J, Wang G, Xu Y, Wang G, Dong P, Jiao Y, Yang J, Ou-Yang J, Jiang H, Zhu Y, Ren S, Zhang Z, Yin C, Wu Q, Zheng Y, Turner AR, Tao S, Na R, Ding Q, Lu D, Shi R, Sun J, Liu F, Zheng SL, Mo Z, Sun Y, Xu J,. A novel germline mutation in HOXB13 is associated with proste cancer risk in Chinese men. Prostate 2012; DOI: 10. 1002/pros.22552 [Epub ahead of print].
16. Karlsson R, Aly M, Clements M, Zheng L, Adolfsson J, Xu J, Gronberg H, Wiklund F,. A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk. Eur Urol 2012; DOI: 10.1016/j.eururo.2012.07.027 [Epub ahead of print].
17. Akbari MR, Trachtenberg J, Lee J, Tam S, Bristow R, Loblaw A, Narod SA, Nam RK,. Association between germline HOXB13 G84E mutation and risk of prostate cancer. J Natl Cancer Inst 2012; 104 (16): 1260-1262.
18. Agalliu I, Salinas CA, Hansten PD, Ostrander EA, Stanford JL,. Statin use and risk of prostate cancer: results from a population-based epidemiologic study. Am J Epid 2008; 168 (3): 250-260.
19. Stanford JL, Wicklund KG, McKnight B, Daling JR, Brawer MK,. Vasectomy and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 1999; 8 (10): 881-886.
20. Waksberg J,. Sample methods for random digit dialing. J Am Stat Soc 1978; 73: 40-46.
21. Wright JL, Salinas CA, Lin DW, Kolb S, Koopmeiners J, Feng Z, Stanford JL,. Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4 + 3 and Gleason 3 + 4 tumors in a population based cohort. J Urol 2009; 182 (6): 2702-2707.
22. Holt SK, Kwon EM, Lin DW, Ostrander EA, Stanford JL,. Association of hepsin gene variants with prostate cancer risk and prognosis. Prostate 2010; 70 (9): 1012-1019.
23. Graham A,. Developmental patterning: The Hox code out on a limb. Curr Biol 1994; 4 (12): 1135-1137.
24. Goodman FR, Scambler PJ,. Human HOX gene mutations. Clin Genet 2001; 59: 1-11.
25. Kim SD, Park RY, Kim YR, Kim IJ, Kang TW, Nam KI, Ahn KY, Bae CS, Kim BY, Park SS, Jung C,. HOXB13 is co-localized with androgen receptor to suppress androgen-stimulated prostate-specific antigen expression. Anat Cell Biol 2010; 43 (4): 284-293.
26. Zeltser L, Desplan C, Heintz N,. Hoxb-13: A new Hox gene in a distant region of the HOXB cluster maintains colinearity. Development 1966; 122 (8): 2475-2484.
27. Mortlock DP, Sateesh P, Innis JW,. Evolution of N-terminal sequences of the vertebrate HOXA13 protein. Mamm Genome 2000; 11 (2): 151-158.
28. Shen WF, Montgomery JC, Rozenfeld S, Moskow JJ, Lawrence HJ, Buchberg AM, Largman C,. AbdB-like Hox proteins stabilize DNA binding by the Meis1 homeodomain proteins. Mol Cell Biol 1997; 17 (11): 6448-6458.